Orange Book product · Generic (ANDA)
DOXERCALCIFEROL
DOXERCALCIFEROL
At a glance
Aug 30, 2013
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Aug 30, 2013
13 yr ago
Today
Pharmaceutical detail
Active ingredient
DOXERCALCIFEROL
Strength
4MCG/2ML (2MCG/ML)
Dosage form
INJECTABLE
Route
INJECTION
TE code
Not listed
Application
ANDA 091101
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of DOXERCALCIFEROL
- 2018DOXERCALCIFEROLBrand (NDA)
NDA 208614 · HOSPIRA
- 2004HECTOROLBrand (NDA)
NDA 020862 · SANOFI
- 2000HECTOROLBrand (NDA)
NDA 021027 · SANOFI
- 2023DOXERCALCIFEROLGeneric (ANDA)
ANDA 215810 · ALEMBIC
- 2022DOXERCALCIFEROLGeneric (ANDA)
ANDA 213717 · EUGIA PHARMA
- 2020DOXERCALCIFEROLGeneric (ANDA)
ANDA 205360 · AVET
- 2020DOXERCALCIFEROLGeneric (ANDA)
ANDA 211670 · MEITHEAL
- 2019DOXERCALCIFEROLGeneric (ANDA)
ANDA 203875 · SUN PHARM
- 2019DOXERCALCIFEROLGeneric (ANDA)
ANDA 210452 · GLAND
- 2018DOXERCALCIFEROLGeneric (ANDA)
ANDA 210801 · LUPIN
- 2017DOXERCALCIFEROLGeneric (ANDA)
ANDA 208974 · AMNEAL
- 2017DOXERCALCIFEROLGeneric (ANDA)
ANDA 208975 · AMNEAL
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
